Apogee Therapeutics Total Assets 2023-2025 | APGE

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Apogee Therapeutics total assets from 2023 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Apogee Therapeutics total assets from 2023 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.

Related Stocks
Company Name	Market Cap
AstraZeneca (AZN)	$237.5B
Amgen (AMGN)	$162B
Gilead Sciences (GILD)	$142.8B
Vertex Pharmaceuticals (VRTX)	$120.5B
Bristol Myers Squibb (BMY)	$93.6B
CSL (CSLLY)	$84.5B
GSK (GSK)	$79.6B
Regeneron Pharmaceuticals (REGN)	$59.9B
Alnylam Pharmaceuticals (ALNY)	$44.3B
Argenex SE (ARGX)	$36.7B
BioNTech SE (BNTX)	$26.5B
Royalty Pharma (RPRX)	$20.9B
Insmed (INSM)	$20B
Biogen (BIIB)	$18.6B
Illumina (ILMN)	$16.9B
Incyte (INCY)	$15B
Genmab (GNMSF)	$14.7B
Genmab (GMAB)	$14.3B
Moderna (MRNA)	$12.4B
BioMarin Pharmaceutical (BMRN)	$11.3B
QIAGEN (QGEN)	$11.2B
Swedish Orphan Biovitrum (BIOVF)	$10.6B
Ascendis Pharma (ASND)	$10.2B
Exelixis (EXEL)	$9.9B
Bio-Techne Corp (TECH)	$9B
Verona Pharma American Depositary Share (VRNA)	$9B
Exact Sciences (EXAS)	$8.8B
Blueprint Medicines (BPMC)	$8.3B
Roivant Sciences (ROIV)	$7.7B
Legend Biotech (LEGN)	$7.4B